Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mustafa Nevzat Pharmaceuticals

http://www.mn.com.tr

Latest From Mustafa Nevzat Pharmaceuticals

Pharmaceutical Company News from Turkey

PharmAsia News brings you a look at Turkey’s drug market by capturing recent moves by international and domestic firms.

BioPharmaceutical Medical Device

Regulation, Reimbursement Notes From Turkey

A PharmAsia News update shows Turkey has set a target to domestically manufacture 60% of the drug products used annually and 20% of medical device and equipment by an unspecified timeframe. The government also moved to offer more support into R&D for high-value biopharmaceutical products and sent a large ministerial delegation to the annual Bio Conference in San Diego as a signal of how important the sector is to its public health programs.

BioPharmaceutical Medical Device

Regulation, Reimbursements Notes From Turkey

A PharmAsia News update on Turkish biomedical regulatory policies, including reports that the government offered industry to keep discount rates secret and an 11.7% jump in exports in the first four months of 2014.

BioPharmaceutical Turkey

Regulation, Reimbursement Notes From Turkey

A PharmAsia News update on Turkish biomedical regulatory policies, including a penicillin shortage and an update on a draft patent law.

BioPharmaceutical Turkey
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
UsernamePublicRestriction

Register